TipRanks
Advertisement
Advertisement
Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device
PremiumCompany AnnouncementsNyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device
24d ago
Nyxoah’s ACCCESS Trial Hits Key Endpoints for Genio in Complex Sleep Apnea Patients
Premium
Company Announcements
Nyxoah’s ACCCESS Trial Hits Key Endpoints for Genio in Complex Sleep Apnea Patients
29d ago
Nyxoah announces ACCESS study meets primary safety, efficacy endpoints
Premium
The Fly
Nyxoah announces ACCESS study meets primary safety, efficacy endpoints
29d ago
Nyxoah price target lowered to $4 from $13 at Oppenheimer
PremiumThe FlyNyxoah price target lowered to $4 from $13 at Oppenheimer
2M ago
Nyxoah Q2 2026 Results Show Rapid U.S. Growth for Genio Sleep Apnea Therapy
Premium
Company Announcements
Nyxoah Q2 2026 Results Show Rapid U.S. Growth for Genio Sleep Apnea Therapy
2M ago
Nyxoah Sets Date for Q2 2026 Results Amid Global Rollout of Genio Sleep Apnea Therapy
Premium
Company Announcements
Nyxoah Sets Date for Q2 2026 Results Amid Global Rollout of Genio Sleep Apnea Therapy
2M ago
Nyxoah backs FY26 revenue view EUR 36M-EUR 40M
PremiumThe FlyNyxoah backs FY26 revenue view EUR 36M-EUR 40M
3M ago
Nyxoah Secures $15 Million EIB Tranche as June Funding Reaches $110 Million
Premium
Company Announcements
Nyxoah Secures $15 Million EIB Tranche as June Funding Reaches $110 Million
3M ago
Nyxoah price target lowered to $3 from $5 at Stifel
Premium
The Fly
Nyxoah price target lowered to $3 from $5 at Stifel
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―